BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22330412)

  • 1. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder.
    McCutchan JA; Marquie-Beck JA; Fitzsimons CA; Letendre SL; Ellis RJ; Heaton RK; Wolfson T; Rosario D; Alexander TJ; Marra C; Ances BM; Grant I;
    Neurology; 2012 Feb; 78(7):485-92. PubMed ID: 22330412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study.
    Carvalhal A; Gill MJ; Letendre SL; Rachlis A; Bekele T; Raboud J; Burchell A; Rourke SB;
    J Neurovirol; 2016 Jun; 22(3):349-57. PubMed ID: 26572786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive disorders in HIV-infected patients: are they HIV-related?
    Bonnet F; Amieva H; Marquant F; Bernard C; Bruyand M; Dauchy FA; Mercié P; Greib C; Richert L; Neau D; Catheline G; Dehail P; Dabis F; Morlat P; Dartigues JF; Chêne G;
    AIDS; 2013 Jan; 27(3):391-400. PubMed ID: 23079813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of adiposity in HIV/AIDS patients: Agreement between waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index.
    Dimala CA; Ngu RC; Kadia BM; Tianyi FL; Choukem SP
    PLoS One; 2018; 13(3):e0194653. PubMed ID: 29566089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons.
    Crum-Cianflone NF; Moore DJ; Letendre S; Poehlman Roediger M; Eberly L; Weintrob A; Ganesan A; Johnson E; Del Rosario R; Agan BK; Hale BR
    Neurology; 2013 Jan; 80(4):371-9. PubMed ID: 23303852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection.
    Hulgan T; Kallianpur AR; Guo Y; Barnholtz-Sloan JS; Gittleman H; Brown TT; Ellis R; Letendre S; Heaton RK; Samuels DC;
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e95-e102. PubMed ID: 30531306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.
    Jia P; Zhao Z; Hulgan T; Bush WS; Samuels DC; Bloss CS; Heaton RK; Ellis RJ; Schork N; Marra CM; Collier AC; Clifford DB; Gelman BB; Sacktor N; Morgello S; Simpson DM; McCutchan JA; Barnholtz-Sloan JS; Franklin DR; Rosario D; Letendre SL; Grant I; Kallianpur AR;
    Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):413-426. PubMed ID: 28447399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and diagnosis of neurocognitive impairment in HIV-positive patients.
    Pinheiro CA; Souza LD; Motta JV; Kelbert EF; Souza MS; Martins CS; Coelho FM; Pinheiro KA; Pinheiro RT
    Braz J Med Biol Res; 2016 Sep; 49(10):e5344. PubMed ID: 27626305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.
    Hulgan T; Samuels DC; Bush W; Ellis RJ; Letendre SL; Heaton RK; Franklin DR; Straub P; Murdock DG; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I; Kallianpur AR;
    Clin Infect Dis; 2015 Nov; 61(9):1476-84. PubMed ID: 26129753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study.
    Marquine MJ; Montoya JL; Umlauf A; Fazeli PL; Gouaux B; Heaton RK; Ellis RJ; Letendre SL; Grant I; Moore DJ;
    Clin Infect Dis; 2016 Sep; 63(5):694-702. PubMed ID: 27199461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.
    Morgan EE; Woods SP; Letendre SL; Franklin DR; Bloss C; Goate A; Heaton RK; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Ellis RJ; Abramson I; Gamst A; Fennema-Notestine C; Smith DM; Grant I; Vaida F; Clifford DB;
    J Neurovirol; 2013 Apr; 19(2):150-6. PubMed ID: 23408335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.
    Heaton RK; Franklin DR; Ellis RJ; McCutchan JA; Letendre SL; Leblanc S; Corkran SH; Duarte NA; Clifford DB; Woods SP; Collier AC; Marra CM; Morgello S; Mindt MR; Taylor MJ; Marcotte TD; Atkinson JH; Wolfson T; Gelman BB; McArthur JC; Simpson DM; Abramson I; Gamst A; Fennema-Notestine C; Jernigan TL; Wong J; Grant I; ;
    J Neurovirol; 2011 Feb; 17(1):3-16. PubMed ID: 21174240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment.
    Marquine MJ; Umlauf A; Rooney AS; Fazeli PL; Gouaux BD; Paul Woods S; Letendre SL; Ellis RJ; Grant I; Moore DJ;
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):190-7. PubMed ID: 24442225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in weight and weight distribution across the lifespan among HIV-infected and -uninfected men and women.
    Erlandson KM; Zhang L; Lake JE; Schrack J; Althoff K; Sharma A; Tien PC; Margolick JB; Jacobson LP; Brown TT
    Medicine (Baltimore); 2016 Nov; 95(46):e5399. PubMed ID: 27861378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical exercise is associated with less neurocognitive impairment among HIV-infected adults.
    Dufour CA; Marquine MJ; Fazeli PL; Henry BL; Ellis RJ; Grant I; Moore DJ;
    J Neurovirol; 2013 Oct; 19(5):410-7. PubMed ID: 23934585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
    Ding Y; Lin H; Shen W; Wu Q; Gao M; He N
    J Neuroimmune Pharmacol; 2017 Dec; 12(4):661-669. PubMed ID: 28470583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study.
    Pasipanodya EC; Montoya JL; Campbell LM; Hussain MA; Saloner R; Paolillo EM; Jeste DV; Letendre SL; McCutchan JA; Heaton RK; Moore DJ
    Arch Clin Neuropsychol; 2021 Feb; 36(2):151-164. PubMed ID: 31696212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
    Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
    J Neurovirol; 2017 Feb; 23(1):106-112. PubMed ID: 27400930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study.
    Hadaegh F; Zabetian A; Harati H; Azizi F
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):310-5. PubMed ID: 16868890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.